Neratinib-Induced Duodenal Ulcer: A Case Report

We report a case of a 37-year-old woman who developed a duodenal ulcer while receiving adjuvant neratinib for HER2 positive breast cancer. The clinical course of abdominal pain was strongly correlated with the use of neratinib. An esophagogastroduodenoscopy (EGD) was performed and confirmed the diag...

Descripción completa

Detalles Bibliográficos
Autores principales: Moftakhar, Bahar, Kharel, Prakash, Niraula, Sujan, Gandhi, Shipra, Falkson, Carla, Dhakal, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315670/
https://www.ncbi.nlm.nih.gov/pubmed/32636634
http://dx.doi.org/10.1177/1178223420935871

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7315670/
https://www.ncbi.nlm.nih.gov/pubmed/32636634
http://dx.doi.org/10.1177/1178223420935871

Ejemplares similares